GLOBAL BLOOD THERAPEUTICS, INC. (GBT) stock prices updated...
 

GLOBAL BLOOD THERAPEUTICS, INC. stock price

GLOBAL BLOOD THERAPEUTICS, INC. latest news:


  • 11/02/2017 15:07:12

    BRIEF-Global Blood Therapeutics posts Q3 loss per share $0.66

    * Global Blood Therapeutics reports recent business progress and provides third quarter 2017 financial results

  • 10/23/2017 14:07:17

    Global Blood Therapeutics stock declines after forsaking half its drug pipeline

    The pressure is on for GBT440 to succeed in sickle cell disease, which could bring in billions of dollars in revenue. Biotech Global Blood Therapeutics Inc. shares declined in Monday trade after the company announced that it is axing research that amounts to half of its drug development pipeline. Global Blood Therapeutics (GBT) had been studying its main, and only, drug GBT440 in two conditions, idiopathic pulmonary fibrosis and sickle cell disease, which affect the body in different...

  • 10/03/2017 14:14:15

    BRIEF-Point72 Asset Management LP reports 5.2 pct passive stake in Global Blood Therapeutics

    * Point72 Asset Management LP reports 5.2 percent passive stake in Global Blood Therapeutics Inc ‍​as of October 2 - SEC filing Source text: (http://bit.ly/2yH9e9Y) Further company coverage:

  • More trends:

    Global Defense & National Security Systems, Inc.GDEF | Global Eagle Entertainment Inc.ENT | Global Indemnity plcGBLI | Global Indemnity plcGBLIZ | Global Partner Acquisition Corp.GPAC | Global Partner Acquisition Corp.GPACU | Global Partner Acquisition Corp.GPACW | Global Sources Ltd.GSOL | Global X Guru Activist ETFACTX | Global X search China Technology ETFQQQC |